InsidersTradesSigma
Follow the Basilea Pharmaceutica AG, Allschwil stock price and the full insider trade history of the company, a publicly traded company based in Switzerland. Shares trade on the CH market, under the supervision of SIX SER. Operating in the Healthcare & Pharma sector, Basilea Pharmaceutica AG, Allschwil has logged 41 public disclosures. The latest transaction was filed on 7 September 2026 (Sale). The full history is openly available.
41
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€3m
41 ops.
Sell Volume
38Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 September 2026
Declarations41 total
●
Anonymous (an executive member of the board of directors / member of senior management)
303 shares@ CHF 62.90SIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q9700071
●
Anonymous (an executive member of the board of directors / member of senior management)
710 shares@ CHF 66.554.4% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q9300047
●
Anonymous (an executive member of the board of directors / member of senior management)
3,273 shares@ CHF 64.8819.6% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q9200023
●
Anonymous (an executive member of the board of directors / member of senior management)
642 shares@ CHF 64.255.0% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q8O00050
●
Anonymous (an executive member of the board of directors / member of senior management)
2,902 shares@ CHF 64.1624.0% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q8L00064
854 shares@ CHF 63.96100.0% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q8L000B4
●
Anonymous (an executive member of the board of directors / member of senior management)
500 shares@ CHF 60.3011.4% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q8J00027
●
Anonymous (an executive member of the board of directors / member of senior management)
2,000 shares@ CHF 59.7426.5% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q8J00092
●
Anonymous (an executive member of the board of directors / member of senior management)
5,070 shares@ CHF 13.2614.9% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q8J000A0
●
Anonymous (an executive member of the board of directors / member of senior management)
2,401 shares@ CHF 59.0323.9% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q8J000C6
●
Anonymous (Executive member of the board of directors / member of senior management)
2,401 shares@ CHF 59.029811.0% of flowISIN CH0011432447SIX:T1Q8J000C6
●
Anonymous (Executive member of the board of directors / member of senior management)
2,000 shares@ CHF 59.73999.3% of flowISIN CH0011432447SIX:T1Q8J00092
●
Anonymous (Executive member of the board of directors / member of senior management)
5,070 shares@ CHF 13.26435.2% of flowISIN CH0011432447SIX:T1Q8J000A0
●
Anonymous (Executive member of the board of directors / member of senior management)
500 shares@ CHF 60.302.3% of flowISIN CH0011432447SIX:T1Q8J00027
●
Anonymous (an executive member of the board of directors / member of senior management)
400 shares@ CHF 52.009.1% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q5T000F0
●
Anonymous (an executive member of the board of directors / member of senior management)
1,043 shares@ CHF 56.2028.2% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q5D00067
●
Anonymous (Executive member of the board of directors / member of senior management)
1,043 shares@ CHF 56.206.5% of flowISIN CH0011432447SIX:T1Q5D00067
●
Anonymous (an executive member of the board of directors / member of senior management)
400 shares@ CHF 54.0010.4% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q4U000C5
●
Anonymous (Executive member of the board of directors / member of senior management)
400 shares@ CHF 54.002.4% of flowISIN CH0011432447SIX:T1Q4U000C5
●
Anonymous (an executive member of the board of directors / member of senior management)
1,000 shares@ CHF 56.4027.1% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q4K000A1
●
Anonymous (Executive member of the board of directors / member of senior management)
1,000 shares@ CHF 56.406.2% of flowISIN CH0011432447SIX:T1Q4K000A1
●
Anonymous (an executive member of the board of directors / member of senior management)
1,000 shares@ CHF 56.0026.8% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q4H00053
●
Anonymous (Executive member of the board of directors / member of senior management)
1,000 shares@ CHF 56.006.1% of flowISIN CH0011432447SIX:T1Q4H00053
●
Anonymous (an executive member of the board of directors / member of senior management)
1,500 shares@ CHF 10.407.5% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q4F000D2
●
Anonymous (Executive member of the board of directors / member of senior management)
1,500 shares@ CHF 10.401.7% of flowISIN CH0011432447SIX:T1Q4F000D2
25 of 41 declarations
关于 Basilea Pharmaceutica AG, Allschwil
Basilea Pharmaceutica AG 总部位于奥尔施维尔，是一家在瑞士SIX Swiss Exchange (SMI/SPI) 上市的瑞士生物制药公司，股票代码为BSLN。Basilea 成立于2000年，并于2004年上市，已从一个更广泛的研发组织发展成为一家专注于严重细菌和真菌感染的商业化专业公司。其战略定位集中在未满足医疗需求高的领域，其中抗菌素耐药性、危及生命的疾病负担以及有限的治疗选择支持了差异化且相对防御性的投资案例。该公司结合了已上市产品、许可/合作伙伴主导的商业化以及开发管线，使其拥有经常性收入敞口和管线选择权的组合。 Basilea 的商业模式围绕两大支柱。首先，它通过国际合作伙伴商业化抗感染药物，从而限制了对大型自有销售团队的需求，同时保留了经济上行空间。其次，它在其核心治疗特许经营权中推进新资产。主要产品和资产包括 Zevtera® (ceftobiprole medocaril)，该产品于2025年通过合作伙伴 Innoviva Specialty Therapeutics 在美国实现商业化，以及 Cresemba®/isavuconazole，这是一种通过许可和分销协议对集团具有历史重要性的主要抗感染资产。在管线方面，Basilea 正在推进 fosmanogepix（一种同类首创的抗真菌药物）和 BAL2062。2025年，该公司启动了 fosmanogepix 治疗侵袭性霉菌感染的3期研究，并从 BARDA 获得了额外的39 million美元，以继续开发 fosmanogepix 和 BAL2062，这突显了该特许经营权的外部验证。 在竞争方面，Basilea 占据了一个专业利基市场，而非规模驱动的市场地位。其护城河基于深厚的感染疾病专业知识、新颖的作用机制以及能够支持资本效率的合作伙伴模式。该公司最近强调，它已实现盈利，并且市场销售额以两位数的速度增长，而其2025年全年业绩报告指出强劲的运营表现以及对2026年持续两位数增长的预期。商业吸引力与管线进展的这种结合对于评估执行风险的投资者至关重要。 从地理上看，Basilea 总部位于瑞士，但业务遍及国际，对美国和欧洲有重要的商业敞口，并且开发项目得到了美国机构的支持。对于SIX Swiss Exchange (SMI/SPI) 上的投资者而言，Basilea 代表了一家专注于抗感染药物的瑞士医疗保健股票，具有近期积极的运营势头，其估值故事可能仍将由临床里程碑、合作经济学和商业扩张速度驱动。
